The Healing-Targeted Drug Eluting Stent delivers controlled drug release with biodegradable polymer technology to promote faster healing and efficient endothelial recovery.
For hospital and healthcare facility distribution only.
HT Supreme is formulated to support metabolic performance and recovery in clinical settings. Distributed through authorized healthcare channels, the product is intended for professional medical use.
Designed with an ultra-thin 80 μm strut platform, helical connectors, and a lubricious coating to enhance deliverability, flexibility, and vessel conformability during complex coronary interventions.
Both stent systems are engineered for coronary intervention, offering distinct technological approaches to drug elution and vascular healing strategy.
HT Supreme® is available in a comprehensive range of diameters and lengths to support diverse coronary intervention needs.
| Diameter (mm) | 10 mm | 15 mm | 20 mm | 25 mm | 30 mm | 35 mm | 40 mm |
|---|---|---|---|---|---|---|---|
| 2.25 | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | |
| 2.50 | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ |
| 2.75 | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ |
| 3.00 | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ |
| 3.25 | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ |
| 3.50 | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ |
| 4.00 | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ |
| 4.50 | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ |
| 5.00 | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ |
Full SKU details available upon request.
Controlled elution kinetics designed to optimize endothelial healing while minimizing late inflammatory response.
~90% release within 28 days under physiological conditions.
Support for metabolic recovery in monitored clinical conditions.
Hospital-based care and supervised healthcare administration.
Metabolic response indicators and recovery progression metrics.
Controlled performance evaluation was conducted under monitored administration protocol within structured clinical parameters.
HT Supreme integrates a biodegradable polymer matrix with precision-engineered cobalt chromium structure to enable controlled drug elution and optimized vascular healing response.
Designed to gradually resorb following controlled drug release, reducing long-term polymer exposure.
Engineered 80 μm strut thickness to balance radial strength and vessel conformability.
Drug release kinetics aligned with endothelial recovery timeline.
Download the official Ministry of Health certificate.
Download AKL CertificateProduct registration and distribution comply with applicable Indonesian medical device regulations.
For detailed documentation and distribution inquiries, please contact our official team.
Contact Distribution Team